European Health Claims for Small and Medium-Sized Companies – Utopian Dream or Future Reality?

Journal Title: Functional Foods in Health and Disease - Year 2015, Vol 5, Issue 2

Abstract

Background: In December 2007, the European Regulation (EC) 1924/2006 on nutrition and health claims came into force. The European Union wanted to regulate the use of health claims on products. An online survey was carried out to evaluate the situation, particularly of small and medium-sized companies, dealing with the new regulation. Methods: The online survey on health claims was conducted with 16 enterprises. To underline the findings a SWOT (Strength, Weaknesses, Opportunities, Threats) analysis was made of the nutrition and health claims regulation regarding small and medium-sized companies in the European food and drink market. Results: The findings of this study indicated that the European Union did a step in the right direction. Most companies defined the decent competition, the simplified trade within the inner-European market, and the consumer protection as positive aspects. The biggest threat is seen in false investment conditioned by the limited research and development budgets, especially of small and medium-sized enterprises, and the cost intensive scientific evaluation to reach an authorized health claim. Conclusions: Overall, there are several strengths and opportunities speaking for SMEs and health claims in the near future. The most promising ones are the publishing of the new European Union Register of Nutrition and Health Claims and the learning effects that will occur. The biggest threat is, and will remain to be, false investment and the possible loss of a lot of money. Nevertheless, health claims for small and medium-sized enterprises will inevitably be the future to keep the European food and drink market competitive.

Authors and Affiliations

Keywords

Related Articles

Effects of selected antioxidant food extracts on postprandial glucose responses in healthy individuals

Background: Obesity and diabetes are highly prevalent in Western countries, and both conditions can be associated with impaired glucose control and hyperglycemia. Antioxidants have been identified as having the ability t...

A methanolic extract of Trigonella foenum-graecum (fenugreek) seeds regulates markers of macrophage polarization.

Background: Macrophages are key cellular mediators in diabetes-related inflammation. Molecular cues such as cytokines found in the tissue microenvironment regulates the polarization of macrophages into an M1 (pro-inflamm...

Reduction of blood pressure by aronia berries through inhibition of angiotensin-converting enzyme activity in the spontaneously hypertensive rat kidney

Background: Aronia berries contain many important effects on potential health, with previous studies suggesting that aronia juice is useful for the treatment of hypertension. Objective: To examine whether aronia berries...

Accumulation of solvent-soluble and solvent-insoluble antioxidant phenolics in edible bean sprouts: implication of germination

Background: Edible bean sprouts are popular fresh vegetables widely recognized for their nutritional quality. However, while their antioxidant capacity and phenolic composition in both solvent-soluble and solvent-insolub...

Metformin inhibits expression of the proinflammatory biomarker inducible nitric oxide synthase in hepatocytes

Background: Metformin is used to treat patients with type II diabetes. However, there are few scientific reports on its anti-inflammatory effects. In the inflamed liver, proinflammatory cytokines stimulate liver cells, f...

Download PDF file
  • EP ID EP471989
  • DOI 10.31989/ffhd.v5i2.170
  • Views 141
  • Downloads 0

How To Cite

(2015). European Health Claims for Small and Medium-Sized Companies – Utopian Dream or Future Reality?. Functional Foods in Health and Disease, 5(2), 44-56. https://europub.co.uk/articles/-A-471989